ArticleCancer medicine2025
High Prevalence of Human Papillomavirus in Vulvar Cancer Among Vietnamese Women: Implications for Vaccination Strategies.
Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVulvar cancer (VC) is rare; however, its incidence has steadily increased, likely due to increased human papillomavirus (HPV) infections. HPV infection rates vary significantly with age and ethnicity. Data on the VC incidence in Vietnam are limited.
objectivesThis study aimed to determine HPV infection rates and high-risk HPV types (HR-HPVs) and to model HPV causality in co-infections using a Proportional Attribution (PropAttr) model in Vietnamese VC patients.
methodsWe investigated primary VC cases (invasive carcinoma) diagnosed at our hospital during 2020-2021. Tumor samples were tested for HPV using quantitative polymerase chain reaction. Recurrent cases and poor-quality preserved tumor samples were excluded. HPV infection status, HR-HPV status, and relevant clinicopathological features were analyzed. To estimate the most likely causative HPV genotype in co-infected lesions, the PropAttr model was applied, attributing genotypes based on their prevalence in mono-infections. Model reliability was validated using Spearman's correlation analysis.
resultsOf the 95 cases, 95% were squamous cell carcinoma, and 40% were clinical stage I. The HPV infection rate was approximately 77% (68.4-85.2), and HPV-16 was the most common subtype. Patients infected with HPV (mean age: 62.8) were younger than those who were not infected (mean age: 71.4) in univariate (p = 0.004) and multivariate (p < 0.001) analyses. While the vulvar pathohistological type was significantly associated with HPV infection in multivariate analysis (p < 0.001), no significant relationship was observed with other factors in univariate and multivariate analyses. The PropAttr model showed significant correlations between attribution estimates and mono-infection prevalence (HPV-16: ρ = 0.806, p < 0.001; HPV-18: ρ = 0.992, p < 0.001; 12 other HR-HPVs: ρ = 0.880, p < 0.001). A strong negative correlation between HPV-16 and 12 other HR-HPVs (ρ = -0.751, p < 0.001) suggested competitive interactions in genotype assignment.
conclusionsThe HPV infection rate in Vietnamese VC cases was substantially higher than in other Asian populations, indicating a significant public health burden. Our findings reinforce the importance of expanding national HPV vaccination programs and incorporating advanced attribution models to improve HPV-related cancer risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.